Unique Plan Description: bivalirudin (Angiomax) 250 mg/NS 50 mL (MH/FH)
Plan Selection Display: bivalirudin (Angiomax) 250 mg/NS 50 mL (MH/FH)
PlanType: Medical                                 
Version: 2          
Begin Effective Date: 2020-04-21 15:05:00
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2021-12-21 12:37:40
Available at all facilities: Yes

bivalirudin (Angiomax) 250 mg/NS 50 mL (MH/FH)
IV Solutions
		For CrCl >or = 30 mL/min(NOTE)*
	bivalirudin 250 mg/NS 50 mL
		250 mg, EVERY BAG, 1.75 mg/kg/hr, T;N
		50 mL, IV, STAT, T;N
			Comment: Primary use in Cath Lab, generally not infused post-cath lab.
		For CrCl < 30 mL/min(NOTE)*
		250 mg, EVERY BAG, 1 mg/kg/hr
		50 mL, IV, STAT, T;N
			Comment: Primary use in Cath Lab, generally not infused post-cath lab.
		For dialysis dependent patients(NOTE)*
		250 mg, EVERY BAG, 0.25 mg/kg/hr
		50 mL, IV, STAT, T;N
			Comment: Primary use in Cath Lab, generally not infused post-cath lab.

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase